000 | a | ||
---|---|---|---|
999 |
_c7953 _d7953 |
||
003 | OSt | ||
005 | 20190314110326.0 | ||
008 | 181224b xxu||||| |||| 00| 0 eng d | ||
040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
100 |
_97138 _aBaskaran, R. |
||
245 | _aPoly(lactic-co-glycolic acid) Microspheres Containing a Recombinant Parathyroid Hormone (1-34) for Sustained Release in a Rat Model | ||
250 | _aVol. 80(05), September-October | ||
260 |
_aMumbai _c2018 _bIndian Journal of Pharmaceutical Science |
||
300 | _a837-843 | ||
520 | _aRecombinant parathyroid hormone (1-34), the drug of choice for treating severe osteoporosis, has a short half-life and requires daily subcutaneous injections. Controlled release formulation of recombinant parathyroid hormone (1-34) might prevent daily injections and improve therapeutic outcome. In this study, recombinant parathyroid hormone (1-34)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion method were prepared. Scanning electron microscopy proved that the microspheres were spherical in shape with 2.0 to 5.0 µm diameter. A loading efficiency up to 84 % was achieved in the optimized formulation. Release study performed using microspheres of 10:1.0 polymer:drug ratio formulation revealed that the release of recombinant parathyroid hormone (1-34) was controlled over 22 days in a biphasic manner with an initial burst and a subsequent slow release. For pharmacokinetic study, recombinant parathyroid hormone (1-34)-loaded poly(D,L-lactic-co-glycolic acid) microspheres were subcutaneously injected to rats at 0.01 mg/kg dose of recombinant parathyroid hormone (1-34). Plasma drug concentration of recombinant parathyroid hormone (1-34)-loaded poly(D,L-lactic-co-glycolic acid) microspheres were maintained for a week whereas free recombinant parathyroid hormone (1-34) was quickly eliminated within a day. These results suggest that recombinant parathyroid hormone (1-34)-loaded poly(D,L-lactic-co-glycolic acid) microspheres appear to have the potential for further clinical development. | ||
650 | 0 |
_94639 _aPHARMACEUTICS |
|
653 | _aOsteoporosis | ||
700 |
_97139 _aLee, C. J. |
||
700 |
_97140 _aKang, S. M. |
||
773 | 0 |
_x0250-474X _dNew Delhi Indian Pharmaceutical Association _tIndian journal of pharmaceutical sciences |
|
856 |
_yClick here _uhttp://www.ijpsonline.com/articles/polylacticcoglycolic-acid-microspheres-containing-a-recombinant-parathyroid-hormone-134-for-sustained-release-in-a-rat-model-3537.html |
||
942 |
_2ddc _cAR |